4th Edition Drug Pricing Transparency Congress
March 26, 2019 - Philadelphia MA US
CBI a division of UBM Americas
Tracking Emerging State Price Transparency, Reporting and Disclosure Laws to Ensure Compliance State drug pricing regulations remain in the headlines as state legislatures across the nation continue to introduce and pass laws aimed at transparency and reporting obligations leaving many unanswered questions and a myriad of legislative and compliance complexities. Are you prepared for the impact on drug pricing and compliance practices? CBI’s 4th Edition Drug Pricing Transparency Congress features sessions including: Review drug pricing transparency legislative and litigation developments — including a deep dive state-by-state analysis of laws in Oregon, California, Nevada, Connecticut, New York and Vermont Explore how the future of drug pricing transparency regulation will impact commercialization, reimbursement and drug pricing models Deliver comprehensive legal interpretations of drug pricing transparency and reporting laws currently on the books and the policy outlook for 2019 Benchmark overall state compliance practices related to drug pricing reporting Discuss organizational shifts within legal and compliance departments to handle drug pricing obligations and reporting Don’t miss this timely event — register today!